ABSTRACT BACKGROUND Despite great advances in assisted reproductive technology,
poor ovarian response (POR) is still considered as one of the most challenging tasks in …

Women with impaired ovarian reserve or poor ovarian response (POR) to exogenous
gonadotropin stimulation present a challenge for reproductive specialists. The primary …

In reproductive medicine little progress has been achieved regarding the clinical
management of patients with a reduced ovarian reserve or poor ovarian response (POR) to …

Background Management of women with reduced ovarian reserve or poor ovarian response
(POR) to stimulation is one of the major challenges in reproductive medicine. The primary …

STUDY QUESTION How does the efficacy and safety of a fixed-ratio combination of
recombinant human FSH plus recombinant human LH (follitropin alfa plus lutropin alfa; r …

Background: Growth hormone (GH) is used as an adjuvant therapy in in vitro fertilization and
embryo transfer (IVF-ET) for poor ovarian responders, but findings for its effects on outcomes …

Objective To assess the role of recombinant human LH (r-hLH) supplementation in ovarian
stimulation for ART in specific subgroups of patients. Design Systematic review. Setting …

Poor responders are described as those In Vitro Fertilization (IVF) patients who are failing to
respond to controlled ovarian stimulation protocols. Extensive research has focused on …

Injection of intraovarian platelet-rich plasma (PRP) was recently presented in terms of
improvement ovarian function in women with a poor ovarian response (POR) or primary …

Setting Luteinizing hormone (LH) and human chorionic gonadotropin (hCG) act on the same
receptor, activating different signal transduction pathways. The role of LH or hCG addition to …